Markets

U.S. open in 4 hrs, 21 mins
10,058.64
150.25
 
1.52%
2,150.87
24.82
 
1.17%
1,070.52
13.78
 
1.30%
97.781
-0.6562
 
0.67%
5,139.10
27.26
 
0.53%
9,963.99
31.09
 
0.31%
19,922.22
131.94
 
0.67%
0.0138
 
1.01%
0.54
 
0.61%
1,076.00
-1.20
 
0.11%
73.45
-0.30
 
0.41%
Bookmark and Share

Acadia 3Q loss narrows on revenue boost

AP
posted: 92 DAYS 10 HOURS AGO
Text SizeAAA
SAN DIEGO -Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners.
The development-stage biopharmaceutical company lost $8.7 million, or 23 cents per share, compared with a loss of $15.6 million, or 42 cents per share, during the same period a year prior. Revenue surged to $2.4 million from $282,000, mainly on the company's collaboration with Biovail.
Analysts expected a loss of 24 cents per share.
The company is working with Biovail on pimavanserin as a potential Parkinson's disease treatment and schizophrenia therapy. They've been partners since May.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2009-11-09 18:27:37
COMMENTS ( 0 )
GOT SOMETHING TO SAY?
YOU'LL BE ASKED TO REGISTER OR SIGN IN BEFORE POSTING A COMMENT.
Make a Comment
Comment
 
Download the Daily Finance iPhone Application

Headlines From AOL Money & Finance Partners

CNBC
The Big Money
Smart Money
Kiplinger.com
The street